🟢 Kodiak Sciences is trading 4.8% up in pre-market; catalyst unclear

Kodiak Sciences is trading at $85.00, up +4.82%, with no identified catalyst for its October 15 pre-market rise.

• No new company-specific announcement explaining the rise was identified; Kodiak’s latest listed release is dated October 7.
• The September 28 DAYBREAK update reported both treatments met primary endpoints, but predates the move.
• The broader backdrop is risk-off after hotter-than-expected inflation, which does not explain the rise. No pre-market volume or activity data was provided.